EpiPen Pricing Controversy Reveals Ignorance about Market Competition

by | Jun 26, 2018

EpiPen Pricing Controversy Reveals Ignorance about Market Competition

by | Jun 26, 2018

A recent episode of CNN’s Boss Files podcast featured Heather Bresch, CEO of Mylan and the first woman to run a Fortune 500 pharmaceutical company. The podcast focused primarily on her journey to success. However, roughly 40 minutes in, Bresch was questioned about her pricing strategy for EpiPen, the epinephrine auto-injector for treating emergency allergic reactions.
Mylan acquired the right to sell EpiPen in 2007 and, under Bresch’s leadership, EpiPen prices were raised nearly 400 percent in late 2015. In mid-2016, Mylan released a generic EpiPen, which sold for about $300 for a 2-pack (50 percent less expensive than the name-brand version). When questioned about Mylan’s pricing and promotion strategy, Bresch explained that patients “needed a solution and wanted a solution” and that her generic device provided both.
Not everyone is sympathetic to her answer. A recent business column in the Los Angeles Times called her comments “bogus on many levels” and said her actions demonstrate “unfettered corporate greed.” Others compare her to disgraced drug-industry executive Martin Shkreli of Turing Pharmaceuticals. Shkreli, who is now serving time for securities fraud, received sharp criticism when he raised the price of the drug Daraprim from $13.50 to $750 a pill in 2015.
Read the rest at independent.org.

Our Books

latest book lineup.

Related Articles

Related

TGIF: What Should I Do on Election Day?

TGIF: What Should I Do on Election Day?

Democracy is the theory that the common people know what they want, and deserve to get it good and hard. --H. L. Mencken This column was prompted by a conversation I had with a few neighbors, whom I do not know, over the Nextdoor.com platform. I thank them for being...

read more
And the Winner Is…Not You

And the Winner Is…Not You

Of all the government or quasi-government institutions, there is perhaps none as openly opaque in its operations and unaccountable for its failures as the Federal Reserve. For, unlike its top rivals for this most dubious of distinctions, like the CIA, NSA, or DOD,...

read more
Ukraine’s Corruption has Poisoned America

Ukraine’s Corruption has Poisoned America

The U.S. Congress is working towards a bill which would fund Ukraine into 2025. This, of course, is into the next presidential term. As Senator JD Vance recently explained to Tucker Carlson, the idea behind this is that if Donald Trump is again elected it will...

read more
Trump Railroaded: Will Investors Flee?

Trump Railroaded: Will Investors Flee?

You've surely heard about Justice Arthur Engoron in New York imposing a ludicrous $455 million in fines and interest on Donald Trump and his corporation. Kathy Hochul, governor of New York, obviously approves of the decision, but somehow wants to punish Trump in this...

read more

Pin It on Pinterest

Share This